|
MGA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67079999999764E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08479999999067E-05 |
| Normal-vs-Stage2 |
6.758200E-02 |
| Normal-vs-Stage3 |
1.833060E-04 |
| Normal-vs-Stage4 |
7.22050000012686E-07 |
| Stage1-vs-Stage2 |
6.574800E-01 |
| Stage1-vs-Stage3 |
2.871800E-01 |
| Stage1-vs-Stage4 |
6.190100E-02 |
| Stage2-vs-Stage3 |
2.781000E-01 |
| Stage2-vs-Stage4 |
7.354300E-02 |
| Stage3-vs-Stage4 |
2.488800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.09509999999913E-05 |
| Normal-vs-AfricanAmerican |
1.175820E-04 |
| Normal-vs-Asian |
1.635630E-04 |
| Caucasian-vs-AfricanAmerican |
7.642000E-01 |
| Caucasian-vs-Asian |
2.484000E-01 |
| AfricanAmerican-vs-Asian |
2.321600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.2773000002706E-07 |
| Normal-vs-Female |
1.142600E-01 |
| Male-vs-Female |
2.278200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.636160E-04 |
| Normal-vs-Extreme_Weight |
1.31530000002655E-06 |
| Normal-vs-Obese |
1.201640E-03 |
| Normal-vs-Extreme_Obese |
1.415520E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.235600E-01 |
| Normal_Weight-vs-Obese |
4.256200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.967400E-01 |
| Extreme_Weight-vs-Obese |
1.572980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.727800E-01 |
| Obese-vs-Extreme_Obese |
5.448600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.69420000004384E-06 |
| Normal-vs-Age(41-60Yrs) |
9.040100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.78919999996808E-07 |
| Normal-vs-Age(81-100Yrs) |
6.49710000022452E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.638100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.719760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.185600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.238100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.574200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.398300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.66219999999662E-05 |
| Normal-VS-Type2 PRCC |
2.24579999996699E-06 |
| Normal-VS-KIRP CIMP |
<1E-12 |
| Normal-VS-Unclassified PRCC |
6.276200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.259800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.62536650805123E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
5.025900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.31361588273649E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
1.010180E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.82840001104057E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01050000034242E-07 |
| Normal-vs-N1 |
4.584600E-04 |
| Normal-vs-N2 |
2.183000E-04 |
| N0-vs-N1 |
8.869400E-01 |
| N0-vs-N2 |
2.008000E-01 |
| N1-vs-N2 |
4.098000E-01 |
|
|
